35. Psoriasis

Vitamin D levels of adults with psoriasis in a government tertiary hospital

R Abad, M Sison, A Pandapatan, M Frez

A case of adult Filipino male presenting with colocalized psoriasis and segmental vitiligo

S Abalos-babaran, L Frez

Bridging the gap between doctors and PSORIASIS patients

M Abdelmalek

Association between high sensitivity C-reactive protein and subclinical atherosclerosis in patients with psoriasis

Fahimeh Abdollahimajd, Nasim Niknezhad, Fatemeh Rajabi, Hamid Reza Haghighatkhah, Mohammad Nikvar

Impact of psoriasis on the quality of life of the southern Moroccan patient: interest of Skindex-16

M Abid, M Sebbani, S Ben Moussa, O Hocar, N Akhdari, M Amine, S Amal

PSORIATIC ERYTHRODERMA IN HIV-PATIENT WITH TUBERCULOSIS

Uladzimir P. Adaskevich, Andrej L. Barabanau

Type D (distressed) personality in moderate-severe psoriasis patients and its relationship with mood, cardiovascular risk factors and health-related quality of life.

P Aguayo-carreras, A Molina-leyva

EVALUATION OF SEXUAL DYSFUNCTION IN PSORIATIC PATIENTS AND THEIR PARTNERS IN ALEXANDRIA, EGYPT

A Alariny, C Amin, H Elweshahi, S Abbood

ULTRASONOGRAPHY IN THE DIAGNOSIS AND FOLLOW-UP OF PSORIATIC ARTHRITIS

A Albuquerque, V Albuquerque, J Sherlock, M Saraiva

Biologic treatment in patients with moderate to severe prosiasis undertaking hemodialysis: two cases and a literature review

D. Alifakioti, E. Zafiriou, P. Gidarokosta, A. Roussaki-schulze

A TWO MONTH-JOINT PAIN IN PSORIASIS: INITIAL SYMPTOMP OF PSORIATIC ARTHRITIS?

R Anggraeni, K Rieka Sulaikha, N Mulianto

NON-ALCOHOLIC FATTY LIVER DISEASE AMONG ADULT PATIENTS WITH PSORIASIS

C Angulo Prentice, L Bartolo Cuba, A Guarniz Lozano, H Padilla Corcuera, K Roncal Pretel, P Chavez Tarazona

Conserved overall effectiveness of systemic therapies in elderly psoriasis patients - a two-country, multi-center, prospective, non-interventional study

Florian Anzengruber, Lars French, Andreas Körber, Ulrich Mrowietz, Carlo Mainetti, Diamant Thaci, Matthias Augustin, Christina Sorbe, Kristian Reich, Nikhil Yawalkar, Peter Itian, Karolina Papageorgiou, Julia-tatjana Maul, Marc Radtke, Alexander Navarini

A Rare Case Of Psoriasis With Verrucous Appearance

Suby Arora

IL-23/Th17 targeted therapies in SAPHO syndrome. A case series.

F Aubin, D Wendling, F Verhoeven, C Prati

IL-23/Th17 targeted therapies in SAPHO syndrome. A case series

F Aubin, D Wendling, Franck Verhoeven, C Prati

Characteristics and Outcomes of Patients Treated With Apremilast in the Real World: Results From the APPRECIATE Study

M Augustin, M Radtke, Ce Kleyn, C Conrad, P-g Sator, M Stahle, C Bundy, M Cordey, V Koscielny, K Eyerich, Ce Griffiths

The impact of different severity definitions for psoriasis in real-world healthcare

Matthias Augustin, Anna Langenbruch, Mandy Gutknecht, Kristian Reich, Andreas Körber, Dirk Maaßen, Ulrich Mrowietz, Diamant Thaçi, Ralph Von Kiedrowski, Marc A. Radtke

Topology and Quality of Life in Psoriasis under Routine Care – Results from a High-resolution Analysis in 2,009 Patients

Matthias Augustin, Rachel Sommer, Natalia Kirsten, Alexandra Danckworth, Marc Alexander Radtke, Kristian Reich, Diamant Thaci, Wolf- Henning Boehncke, Anna Katharina Langenbruch, Ulrich Mrowietz

RANDOMISED CONTROL TRIAL COMPARING EFFICACY OF AZATHIOPRINE VERSUS METHOTREXATE IN PSORIASIS; A STUDY ON 120 PATIENTS AT TERTIARY CARE HOSPITAL IN SOUTH INDIA

Ambresh Badad

Impact of Mirikizumab Maintenance Dosing on Patients Who Had

The diseases of Liver and Biliary tract in psoriasis and psoriatic arthritis in East Siberia

A. A. Barilo, S.v. Smirnova

TNFA, IL4, IL10, IL12B gene polymorphisms in psoriasis and psoriatic arthritis in Caucasians of East Siberia

A. A. Barilo, M.v. Smolnikova, S.v. Smirnova

Association between single nucleotide polymorphisms IL17A (rs2275913) and IL17F (rs763780) and Psoriasis and Psoriatic arthritis in Caucasians of East Siberia

Anna Barilo, M.v. Smolnikova, S.v. Smirnova

CD19+CD24highCD38high and CD19+CD24highCD38- regulatory B lymphocytes in psoriatic patients

J Bartosinska, J Purkot, D Raczkiewicz, M Kowal, D Krasowska, G Chodorowska, K Giannopoulos

Analysis of main indicators of leukogram in Russian patients with severe psoriasis and psoriasis arthritis.

Nadezhda Batkaeva, Edgem Batkaev, Muslimat Gitinova, Tatyana Korotaeva

The correlation of the heredity factor and age of psoriasis manifestation in Russian patients with severe psoriasis.

Nadezhda Batkaeva, Edgem Batkaev, Muslimat Gitinova, Tatyana Korotaeva

Serum level of anti-gliadin IgA antibody among patients with psoriasis

U Batzorig, Z Ganbat, E Jamiyan, N Batbayar, O Sukhee, D Byamba

Severe nail psoriasis successfully and safely treated with intralesional methotrexate injection: A new observation

M Ben Kahla, S Mokni, K Ameur, R Gammoudi, L Boussofara, A Aounallah, N Ghariani, C Belajouza, M Denguezli, B Sriha, R Nouira

Hepatic abnormalities in psoriasis: prevalence and associated factors of liver fibrosis. A cross sectional study

Imene Ben Lagha, Faten Rebhi, Bahaa Ben Slimane, Soumaya Youssef, Nebil Abdelli, Kahena Jaber, Mohamed Raouf Dhaoui

Study of the correlation of DLQI and Skindex in the assessment of the quality of life in psoriatic patients followed at the University Hospital of Marrakech

S Ben Moussa, M Sebbani, M Abid, O Hocar, N Akhdari, M Amine, S Amal

Onset of Bullous pemphigoid during psoriasis treatment with etanercept and remission with ustekinumab

S. Berbert Ferreira, R. Berbert Ferreira, B. Costa, R. Rosolem, L. Valencio, J. Nakano

Prevalence of psoriasis in Bangladesh.

Msi Bhuiyan, Ms Sikder, M Mostaque, Ak Nandy, A Sultana, R Siddiki

Achieving and Maintaining Long-term Optimal Improvements in Patient-reported Symptoms, Signs, and Quality of Life Among Patients with Moderate to Severe Psoriasis Treated with Guselkumab: 3-year Data

A Blauvelt, C Han, Ka Papp, Cem Griffiths, P Fernandez-penas, Dn Adam, S Philipp, M Song, Y-k Shen, Ab Kimball

Consistency of response maintained across demographic subgroups of psoriasis patients treated with guselkumab for up to 3 years in the VOYAGE 1 and 2 trials

A Blauvelt, K Reich, L Spelman, J Bagel, R Bissonnette, S Gerdes, S Fakharzadeh, M Song, Y-k Shen, K Gordon

Itching and disease duration correlation in patient with psoriasis vulgaris

Y Blyta, N Nixha

Cutaneous dysbiosis: Role of Staphylococcus aureus in patients with psoriasis

C Boncompain, C Suarez, V Belluzo, M Squeff, G Piccirilli, Morbidoni H, A Molteni, R Fernandez Bussy

Functionalized gold nanoparticles for cutaneous delivery of Methotrexate and effects on psoriasis mouse model

E Botti, I Fratoddiit, L Benassi, C Vaschieri, I Venditti, H Bessar, P Azzoni, C Magnoni, A Costanzo, L Bianchi, G Pellacani

Biological therapy for psoriasis in a complex clinical scenario: the prison environment.

Valeria Brazzelli, Stefania Barruscotti, David Michael Abbott, Maddalena Armellini, Fatima Maqsood

“Difficult-to-treat” Psoriasis: more than just a skin disease - A complex clinical case.

Valeria Brazzelli, Stefania Barruscotti, David Michael Abbott, Fatima Maqsood, Maddalena Armellini

Palmoplantar pustulosis and allergies

Alexandra Maria Giovanna Brunasso Vernetti

COMPARING THE EFFICACY OF TOPICAL CORTICOSTEROIDS/308-NM EXCIMER LIGHT COMBINATION THERAPY AND TOPICAL CORTICOSTEROIDS MONOTHERAPY IN MODERATE PSORIASIS VULGARIS

D Cahyawari, Hp Dharmadji, E Sutedja, O Suwarsa

Cutaneous inflammatory reactions in psoriatic patients treated with anti IL 17 therapies

Giacomo Caldarola, Gaia Moretta, Federico Pirro, Laura Calabrese, Magda D'agostino, Ketty Peris, Clara De Simone

Identification of genetic contributors to the progression from Psoriasis to Psoriatic Arthritis

Elena Campione, Raffella Cascella, Roberta Gaziano, Sara Mazzilli, Annamaria Mazzotta, Claudia Strafella, Virginia Garofalo, Valerio Caputo, Annunziata Dattola, Arianna Zangrilli, Daniele Marino, Giuseppe Novelli, Emiliano Giardina, Luca Bianchi

Apremilast for the treatment of active psoriatic arthritis and plaque psoriasis: a single center real-life experience

Elena Campione, Sara Mazzilli, Miriam Teoli, Valeria Manfreda, Caterina Lanna, Carlo Chiaromonte, Alessandro Giunta, Luca Bianchi

Long-term drug survival for infliximab in psoriasis patients.

C Carlet, Ma Richard, E Mahe, C Saillard, E Brenaut, A Villani, M Viguier, C Nardin, F Aubin

Correlation between nail psoriasis severity and ultrasonography changes comparing with controls

S Carneiro, R Grynszpan, I Moss, J.a Mendonça, M Ramos-e-silva

A selective inhibitor of tyrosine kinase 2, BMS-986165, improves molecular, cellular, and clinical biomarkers associated with efficacy in moderate-to-severe psoriasis

Im Catlett, S Hu, S Banerjee, K Gordon, Jg Krueger

Can sunscreen use lead to vitamin D deficiency?

Domenico Centofanti

Pustular psoriasis in Tunisia : A 10-year review

I Chabchoub, H Hammami, A Zaouak, S Fenniche

Disseminated and extra-pulmonary tuberculosis in a patient under anti-tumor necrosis factor-α treatment

Ching Hao Chang, Chu Teh Chen, Chia Wen Shih

An insight into the Colombian Burden of Psoriasis

D Chaparro, G Sanclemente, N Velez, Lm Colmenares, A Motta, E Quevedo, L Charry, Jr Amador, La Castro, Cj Diaz, E Melendez, C Morales, A Argote, O Mora, M Reyes, N Hernandez, Mp Rodriguez, Ms Ramirez, N Cordoba, S Herrera, H Castellanos, F Jaramillo, Residentes Dermatologia, Residentes Dermatologia, Residentes Dermatologia, Residentes Dermatologia, Residentes Dermatologia, Residentes Dermatologia, Residentes Dermatologia, Residentes Dermatologia

Association of multiple sclerosis with psoriasis: a systematic review and meta-analysis of observational studies

Ching-chi Chi, Chia-yu Liu, Chin-yu Lee, Tao-hsin Tung, Kuo-hsuan Chang, Shu-hui Wang

Koebner Phenomenon in Psoriasis due to Herpes Zoster

A. Chiriac, I. Iacovleva, V. Tabarna, V. Sturza, M. Comendant, M. Betiu

Secukinumab effectiveness in treating moderate-severe plaque psoriasis: a European, multicenter, retrospective, real-world, study

A Chiricozzi, A. Balato, C Conrad, A . Conti, P Dapavo, P Ferreira, L Leite, P Malagoli,, P Mendes-bastos, S Piaserico, F Prignano, T Torres

Estimation of plasma homocysteine levels and determination of carotid artery intima media thickness in moderate-severe psoriasis - potential association?

Lakshmi Pooja Chitturi, Satya Saka

Clinical and Immunological Manifestations of Psoriasis Patients with Latent Tuberculosis Infection

Yb Choe, Jy Hong, Jh Kim, Jr Hong, Hi Cheon, Ms Hur, Yw Lee, Kj Ahn

Patients' knowledge about psoriasis and comorbidities; their participation in treatment decisions

Kagan Cingoz, Kamer Gunduz, Isil Inanir

Topical 0.25% Desoximetasone Spray for Treatment-Resistant Psoriasis

A Cline, N Okwundu, L Cardwell, I Richardson, S Feldman

How well do psoriasis patients take methotrexate and can we improve it

A Cline, E Unrue, L Cardwell, H Alinia, R Tull, S Feldman, W Huang

Efficacy and safety of switching to ixekizumab in secukinumab non-responders patients with chronic plaque psoriasis: an italian multicenter study.

Andrea Conti, Paolo Amerio, Giuseppe Argenziano, Anna Balato, Federico Bardazzi, Luca Bianchi, Martina Burlando, Serafinella Patrizia Cannavò, Andrea Chiricozzi, Paolo Dapavo, Clara De Simone, Maria Concetta Fargnoli, Paolo Gisondi, Paolo Malagoli, Giovanna Malara, Cristina Mugheddu, Annamaria Offidani, Francesca Peccerillo, Stefano Piarseico, Francesca Prignano, Luca Stingeni, Giovanni Pellacani

Drug survival of biological therapy in South Brazilian psoriasis patients

E Costa De Lima, N Gollo Mazzotti, P Palominos, J Catucci Boza

The cost of psoriasis in patients under conventional systemic treatment or biologic: the results of a retrospective analysis carried out in an Italian center

Paolo Dapavo, Elisabetta Rostagno, Emanuela Zagni, Delia Colombo, Roberto Ravasio

SEVERE PSORIASIS VULGARIS TREATED WITH MYCOPHENOLATE MOFETIL: A TREATMENT CHALLENGE

H Darmawan, N Nopriyati

Itching and Secukinumab: an observational study

Stefano Dastoli, Martina Silvestri, Luigi Bennardo, Elisabetta Scali, Giusy Schipani, Steven Paul Nisticò

Secukinumab in the treatment of diffucult psoriasic patients: a case series

Stefano Dastoli, Martina Silvestri, Luigi Bennardo, Elisabetta Scali, Giusy Schipani, Steven Paul Nisticò

Real life results in the treatment of psoriasis and psoriatic arthritis with Certolizumab pegol

A Dattola, L Bianchi

Polymorphisms associated with anti-TNF response in patients with psoriasis and psoriatic arthritis

E Dauden, Mc Ovejero-benito, E Muñoz-aceituno, A Reolid, L Hevia, R Prieto-pérez, M Llamas-velasco, F Abad-santos

Expression of miRNAs in Psoriasis. Predictors to treatment response?

E Dauden, P Rodríguez-jiménez, P Chicharro, A Vara, A Sanz-garcía, E Rivas, M Llamas-velasco, H De La Fuente, F Sánchez-madrid

Mood disorders and psoriasis – dermatologists’ knowledge, attitudes and practices in France

Laurène David, Elodie Archier, Agathe Souteyrand, Alain Beauchet, Emmanuel Mahé, Nathalie Quiles

Annular Pustular Psoriasis mimicking Tinea Corporis in a 3-year-old male: a Case Report

J Dayrit, Cj Luis

Effectiveness of etanercept biosimilar SB4 in maintaining low disease activity in psoriasis arthritis patients switched from etanercept originator: an open label study

C De Felice, V Lora, A Morrone, D Graceffa, C Bonifati

PREVALENCE OF METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS

D Demaj, E Vasili, L Kuneshka

Apremilast & Cyclosporine in Psoriasis: A case Report

Dinesh Kumar Devaraj

The role of key signature psoriasis cytokines in adipose tissue inflammation

R Di Caprio, A Balato, G Caiazzo, E Scala, A Raimondo, M Romanelli, A Chiricozzi

Biologic therapies for psoriasis and the risk of acute infections: influence of gender and smoke habits

Antonella Di Cesare, Camilla Bianchi, Elia Rosi, Leonardo Pescitelli, Nicola Pimpinelli, Francesca Prignano

Nail Psoriasis Treated With Certolizumab Pegol in Patients With Psoriatic Arthritis

C Di Raimondo, M Mazzeo, V Manfreda, L Vollono, A Dattola, L Bianchi

Astilbin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing T cells

Tingting Di, Ping Li, Jingxia Zhao, Yan Wang

STUDY OF ASSOCIATION OF PSORIASIS WITH METABOLIC SYNDROME IN INDIAN POPULATION

Ambika Dixit, Praveen Rathore, Sapna Goyal

LONG-TERM ORAL PENICILLIN IN CHRONIC PLAQUE PSORIASIS (CPP): A RANDOMIZED CONTROLLED TRIAL

Luvdeep Dogra, Jaideep Dogra

POSSIBILITIES OF EHELATH DEVICES FOR PSORIASIS PATIENTS TO IMPROVE PATIENTS CARE.

Lena Domogalla, Theresa Schulze-hagen, Johannes Benecke, Schmieder Astrid

Are interleukin 17-induced psoriatic morphological features promptly reverted by a specific biological interleukin 17 inhibitor in a 3D model of normal human skin?

E. Donetti, L. Cornaghi, F. Arnaboldi, G. Lombardo, F.w. Baruffaldi Preis, F. Prignano

The Expression of Syndecan-1 in psoriatic epidermis before and after phototherapy

R .w. Doss, A. El-rifaie, L.a. Rashed, A.n. Sayed

Plaque psoriasis and superimposed tinea: diagnostic dilemma

Silvija Duma, Katerina Damevska, Anita Najdova, Ivana Gjoric

Risankizumab Profile in Nail, Scalp, and Palmoplantar Psoriasis: Efficacy and Safety at 52 Weeks in an Integrated Analysis of Patients With Moderate-to-Severe Plaque Psoriasis

B Elewski, P Rich, J Crowley, P Foley, T Wu, O Reyes-servin, Y Poulin

Efficacy and Safety of Ustekinmab in Treatment of Psoriasis: A Real World Data

Tulin Ergun, Server Serdaroglu, Emel Bulbul Baskan, Nahide Onsun, Murat Borlu, Bengu Gerceker, Sibel Alper, Esra Adisen, Nilgun Atakan, Dilek Seckin Gencosmanoglu

CREATION OF AN INTEGRAL CLINIC FOR PSORIASIS PATIENTS IN HONDURAS

D Espinoza

Individual Burden of Psoriasis (I-BoP): construction and validation of a new score

Khaked Ezzedine, Francois Maccari, Ziad Reguiai, Charles Taieb

Fine mapping and subphenotyping implicates ADRA1B gene variants in psoriasis susceptibility in a Chinese population

Xing Fan, Hongyan Wang, Liangdan Sun, Xiaodong Zheng, Xianyong Yin, Xianbo Zuo, Qian Peng, Kristopher A. Standish, Hui Cheng, Yaohua Zhang, Zaixing Wang, Fengli Xiao, Sen Yang, Xuejun Zhang, Nicholas J. Schork

Involvement of autoinflammation in early phases of psoriasis

D Fanoni, L Venegoni, S Tavecchio, B Vergani, A Cattaneo, E Berti, A Marzano

Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis.

S Farina, A Tett, E Pasolli, D Geat, Dt Truong, F Asnicar, M Zolfo, F Beghini, F Armanini, O Jousson, V De Sanctis, R Bertorelli, G Girolomoni, M Cristofolini, N Segata

Efficacy and safety of guselkumab administered with a novel self-injection device for the treatment of moderate-to-severe psoriasis: Results from the Phase III ORION self-dose study through Week 16

L Ferris, E Ott, Hc Hong, W Baran

Evaluation of the usability and acceptability of a novel, self-injection device for the treatment of moderate-to-severe psoriasis: Results from the Phase III ORION self-dose study

L Ferris, E Ott, G Jiang, C Han, Hc Hong, W Baran

Prevalence and incidence of latent tuberculosis in patients with moderate to severe psoriasis under systemic treatment in the Dermatology Service of the Hospital Universitario Austral.

P Figueroa, C Barbini, Am Parigini, L Eimer, L Suar, A De Pablo, C Busso

Lymph node tuberculosis during adalimumab therapy for severe plaque psoriasis

P Figueroa, L Suar, A Parigini, Mc De Diego, R Gago, J Anaya, A De Pablo, C Busso, L Eimer

FREE VITAMIN D: A NEW LABORATORY TOOL IN PATIENTS WITH PSORIASIS

Angela Filoni, Domenico Bonamonte, Ketty Peris, Giacomo Caldarola, Debora Lobreglio, Giambattista Lobreglio, Maurizio Congedo

First use of biologic treatment for psoriasis in a patient with Cohen syndrome

Ac Fougerousse

Profile of the patients treated by apremilast in a prospective non-interventional, descriptive, multicenter study in France: first results

Ac Fougerousse, D Bouilly-auvray, F Maccari, M Bastien, R Safar, C Girard, E Begon, M Perrussel, M Zeitoun, Jb Montfort, C Jacobzone, P Pfister, E Mahe, V Pallure, D Thomas-beaulieu, B Solyga

Switch between interleukin-17A antagonists for psoriasis: a french multicentric retrospectiove experience

Ac Fougerousse, C Boulard, E Begon, F Maccari, L Mery, H Barthelemy, Ac Cottencin, Jb Monfort, N Sultan, D Lons Danic, J Parier, C Jacobzone, C Girard, Z Reguiai, E Mahe, Gem Resopso

Factors that could influence our choice for initiation of apremilast or methotrexate for psoriasis

Ac Fougerousse, F Maccari, J Parier, C Boulard, Pa Becherel, N Quiles-tsimaratos, T Le Guyadec, D Thomas-beaulieu, B Halioua, E Begon, M Bastien, Jl Perrot, V Pallure, M Steff, P Bilan, P Pfister, A Vermersch, T Boyé, L Mery-bossard, H Maillard, M Kemula, C Girrad, C Poiraud, Jb Monfort, I Kupfer, M Perrussel, D Lons-danic, N Sultan, E Mahé, Gem Resopso

Crossed looks on the dermatologist’s position and the patient’s preoccupations as to psoriasis and pregnancy: preliminary results of the PREGNAN-PSO study

Anne Claire Fougerousse, Charles Cassius, Francois Maccari, Charles Taieb

Topical Application of MS-275 Selectively Decreases the Expression of IL-23 in Imiquimod-induced Psoriasis-like Dermatitis in BALB/c Mice

Matthew Friedland, Hye Jin Chung, Jean McGee

HMGB1 inhibitor effectively alleviates psoriasis-like lesions and inflammatory cytokines in K14-VEGF transgenic mouse

Li-xin Fu, Tao Chen

Involvement of High mobility group box-1 (HMGB1) in imiquimod-induced psoriasis-like mice model

Li-xin Fu, Tao Chen

Paeoniflorin suppresses inflammatory response in imiquimod-induced psoriasis-like mice and peripheral blood mononuclear cells (PBMCs) from psoriasis patients

Li-xin Fu, Tao Chen

Topical treatment with vitamin D3 analogue decreases MDR1-expressing T cells infiltrating in plaque psoriasis

FujToshiharu Fujiyama, Takatsune Umayahara, Kazuo Kurihara, Taisuke Ito, Hideo Hashizume, Yoshiki Tokura

Precision medicine in psoriasis: pharmacogenetics of ustekinumab and secukinumab response in a large cohort of psoriatic patients

M. Galluzzo, C. Albanesi, E. Capoluongo, G. Scaglione, M. Morelli, S. Madonna, C. Scarponi, S. Pallotta, S. D'adamio, E. De Paolis, M. De Bonis, M. Andreani, T. Galluccio, F. Locatelli, G. Girolomoni, L. Bianchi, M. Talamonti

The Correlation of Psoriasis Severity Based on Psoriasis Area and Severity Index and Degree of Nonalcoholic Fatty Liver Based on Controlled Attenuation Parameter

N Gandha, L Wibawa, A Sulaiman, T Jacoeb

Characteristics of generalized pustular psoriasis in the south of Tunisia

Hela Gharbi, Emna Bahloul, Mariem Nouri, Noura Bougacha, Sonia Boudaya, Abderrahmen Masmoudi, Slaheddine Marrakchi, Hamida Turki

Epidemiological and clinical aspects of malignant comorbidities in patients with psoriasis in North-East of Romania

Laura Gheuca Solovastru, Dan Vata, Laura Statescu, Ioana Popescu, Alina Ioana Grajdeanu, Elena Porumb Andrese, Andreea Barbuta

Evaluation of Trans-Epidermal-Water-Loss in psoriatic patients treated with biologic or traditional systemic drugs

Federica Giuliani, Manfredo Bruni, Fabrizio Panarese, Alessandra Capo, Giovanna Meogrossi, Chiara Pascalucci, Valentina Di Gregorio, Maria Gabriella Andreassi, Paolo Amerio

SYSTEMATIC REVIEW AND META-ANALYSIS OF ANTI-INTERLEUKIN-17 IN PSORIASIS AND PSORIATIC ARTHRITIS

Federica Giuliani, Anne Rutjes, Marcello Di Nisio, Fabrizio Panarese, Giulio Gualdi, Paolo Amerio

Inflammation induced by intradermal IL-23 in the ear of mice: a model of psoriasis?

Nuria Godessart, Laura Casals, Ana Blanco, Anna Planagumà, Mercè Pont, Amadeu Gavaldà

Combination Biologic Therapy: Guselkumab plus Adalimumab in a Patient with Psoriatic Disease

M Goldust, U Wollina, Ps Yamauchi

ERUPTIVE LENTIGINOSIS IN RESOLVING PSORIATIC PLAQUES AFTER TREATMENT WITH METHOTREXATE: A CASE REPORT

Mc González-aspillaga, Mb Reeves, H Córdova-jadue, S Toso, L Segovia

THE EXPERIENCE AT THE UNIVERSITY HOSPITAL BASURTO WITH SECUKINUMAB IN THE MODERATE-SEVERE PSORIASIS TREATMENT. 

N Gonzalez-romero, A Orbea, C Gomez-bringas, L Blanch-rius, S Gomez-muga, Rm Izu-belloso

Patient-Reported Improvements in Health-Related Quality of Life by Improvements in Clinician-Rated Psoriasis Severity: A Phase 2 Study Analysis in Patients With Psoriasis Treated With Mirikizumab

M Gooderham, E Edson-heredia, J Li, D Patel, J Guo, J Bagel

Influence of baseline demographics on efficacy of a selective oral TYK2 inhibitor, BMS-986165, in patients with moderate-to-severe plaque psoriasis in a Phase 2, randomized, placebo-controlled trial

M Gooderham, K Papp, K Gordon, P Foley, A Morita, D Thaçi, S Kundu, R Kisa, A Napoli, S Banerjee

Durable Absolute Psoriasis Area and Severity Index Improvement Through 52 Weeks of Risankizumab Treatment: An Integrated Analysis of Patients With Moderate-to-Severe Plaque Psoriasis

M Gooderham, A Pinter, H Photowala, T Zhan, B Strober

Evaluating the influence of baseline disease characteristics on efficacy of a selective oral TYK2 inhibitor, BMS-986165, in patients with moderate-to-severe plaque psoriasis in a Phase 2 trial

K Gordon, K Papp, M Gooderham, D Thaçi, P Foley, A Morita, S Kundu, R Kisa, A Napoli, S Banerjee

Maintenance of PASI 90 Response with Guselkumab Through 3-years (Week 156) Among Week 28 PASI 90 Responders in the VOYAGE 1 Study

Kb Gordon, P Foley, C Leonardi, I Landells, M Song, S Fakharzadeh, Y-k Shen, S Li, R Langley, K Reich

Comparable and consistent efficacy responses with up to 3 years of guselkumab treatment in patients with plaque psoriasis regardless of prior treatment: pooled analysis from the VOYAGE 1 and VOYAGE 2

Kb Gordon, L Guenther, A Pinter, Y-b Choe, M Song, S Li, S Fakharzadeh, Y-k Shen, T-f Tsai

The Effect of Guselkumab on Psoriasis in Patients with Active Psoriatic Arthritis: Results from a Phase 2 Study

Ab Gottlieb, W-h Boehncke, P Helliwell, A Deodhar, Xl Xu, S Xu, Y Wang, Y Zhuang, Ec Hsia

Cost-effectiveness analysis of tildrakizumab for moderate to severe plaque psoriasis in England and Wales

W Green, S Mealing, R Stork, N Blanque Catalina

Auditory system involvement in psoriasis

C Guarneri, F Borgia, F Ciodaro, F Guarneri, V Papaianni, N Catalano, F Galletti, Sp Cannavò

Ixekizumab Results in Persistent Quality of Life Improvements in Patients with Moderate-to-Severe Genital Psoriasis Over One Year of Treatment in a Randomized, Placebo Controlled Clinical Trial

L Guenther, R Burge, J Weisman, A Potts Bleakman, J Erickson, C Bertram, C Ryan

IMPORTANCE OF FOLLOW UP IN DETERMINING PsA PREVALENCE OF PsA IN TURKISH PSORIASIS PATIENTS

Begum Gunes, Sevdem Gulcan, Didem Dizman, Anil Bahali, Tahsin Akaslan, Aylin Revzani, And Nahide Onsun

Ten-year experience in management of psoriasis inpatients in a tertiary hospital in China

Jz Guo, Wh Wang, Cl Zhang

BAFF and BAFF Receptors Expression in Psoriasis

Sherihan H. Allam, Abeer M. Abdelaziz, Nora Darwish, Magdy Elsohafy, Wilma Bergfeld

Comparison of latent tuberculosis prevalence according to systemic anti-psoriatic treatment

J.e. Hahm, S.y. Yang, K.s. Kim, C.w. Kim, S.s. Kim

Serum CRP, Endoglin, E-selectin, and Tie-1 as Biomarkers in Psoriasis

Christopher Haley, Ravi Patel, Uyen Mui, Jennifer Martin, Tianfu Wu, Stephen Tyring

Assessment of psoriasis impact on the partners of patients using the FAMILYPSO questionnaire

B Halioua, F Maccari, J Parier, Ac Fougerousse, Z Reguiai, C Taieb, E Esteve

Study of empathy among the partners of psoriasis patients

B Halioua, F Maccari, Z Reguiai, Ac Fougerousse, J Parier, C Taieb, E Esteve

Prevalence of scalp psoriasis and its possible association with joint involvement: a retrospective study of 1218 cases

M Hamilko De Barros, K Diniz Pacheco, L Guedes, Jc Regazzi Avelleira

Evaluation of Relationships between Psoriasis and Neurologic Disorder Using Sequential Pattern Mining

Ju Hee Han, Suk Jun Lee, Jong Soo Jeon, Jae Woong Yoon, Chul Hwan Bang, Jun Young Lee, Young Min Park, Ji Hyun Lee

miR-183 affects keratinocytes proliferation and psoriasis-like inflammation by targeting 15-LOX through lipoxin A4 signaling

F Hu, X Wang, Jt Xu, Ap Feng, Hx Chen

Expression and immunophenotypes of invariant natural killer T cells in peripheral T cells of Moderate-to-Severe Plaque Psoriasis patients

Yifan Hu, Zeyu Chen, Yu Gong, Yuling Shi

Relapse rate after 12 weeks of continued treatment with ixekizumab and assessing the long-term response rate when switched to ixekizumab following relapse

Yu-huei Huang, Po-ju Lai, Julie Elizabeth Hill, Lovisa Berggren, Wen-shuo Wu, Tsen-fang Tsai

Association of Psoriasis and Behcet’s Disease: Is there a common link ?

Mk Hunjan, Ts Chohan, Rd Situnayake, P Chandratre

Delayed Diagnosis of Psoriasis in a young South Indian female. Is skin colour important to Dermatology?

A. Illango, Rr Patel

The state of the immune status of patients with psoriasis, depending on the strength and vegetative tone of the nervous system.

Abdumalik Ismogilov, Javlon Mullakhanov

Long-term safety of tildrakizumab in patients with moderate-to-severe psoriasis: incidence of major adverse cardiovascular events through 148 weeks from reSURFACE 1 and reSURFACE 2 phase 3 trials

L Iversen, Cem Griffiths, J Lambert, A Peserico, Ab Kimball, I Pau-charles, A Blauvelt, D Thaçi, K Reich

Massive eosinophilia induced by multiple biologic agents in a patient with psoriasis and Turner’s syndrome

S Jain, G Fong, P Lowe

Development of a selective S1P1 receptor agonist, IMMH002, as a potential therapeutic agent for psoriasis

J Jin, Xy Zhang, Nn Xue, M Ji, S Zhang, Yc Wang, Ff Lai, Xg Chen

The lymphocytic receptor CD6: genetic, experimental and in vitro evidence of it's relevant role in psoriasis

M Julià, M Consuegra-fernández, M Martínez-florensa, F Aranda, C Català, N Armiger-borràs, Mt Arias, F Santiago, A Guilabert, C Muñoz, A Esteve, C Ferrándiz, Jm Carrascosa, E Pedrosa, J Romaní, M Alsina, Jm Macaró-galy, F Lozano

Reactive Perforating Collagenosis associated with psoriasis in a diabetic

Bei Kan, Xiang Luo, Haipeng Shi

Durable Efficacy of Tonsillectomy in Patients with SAPHO Syndrome

Yuji Kan, Yasuyuki Sumikawa, Tokimasa Hida, Saeko Ajiki, Takafumi Kamiya, Hisashi Uhara

Drug survival and efficacy of apremilast 52 weeks after drug initiation: Real world data of a Tertiary Outpatient Clinic

Eirini Kapniari, Achilleas Diakomopoulos, Konstantinos Theodoropoulos, Sofia Theotokoglou, Natalia Roboti, Evangelia Papadavid

Impact of Dietary Corn oil and Virgin Coconut Oil on Immunohistochemical and Clinical Markers of Inflammation in Moderate Psoriasis: A Prospective Randomized Controlled Investigator-Blinded Trial

S Katalbas, V Verallo-rowell, J Fuentes-duculan, C Salud-gnilo, S Tuason-de Leon, R Baylon, C Maramba-lazarte

Risk by sex for serious infections, cardiovascular events, and cancer in patients treated with TNF-alpha inhibiting agents for psoriasis: A systematic review and meta-analysis

R.c. Kelm, K.r. Patel, J. Gao, S. Rastogi, L. Serrano, Y. Ali, K. Bhatt, S. Amin, A.e. Laumann, D.p. West, B. Nardone

Resistant and quickly extensive pansclerotic morphea in a child of 2 years: experience with sirolimus

F Kettani, F Hali, K Baline, S Chiheb

Long-term efficacy and safety of guselkumab in psoriasis patients with and without psoriatic arthritis: a pooled analysis from VOYAGE 1 and VOYAGE 2

Ab Kimball, P Foley, D Thaci, R Vender, M Song, S Li, S Fakharzadeh, Y-k Shen, A Armstrong

Quality of life and sexuality in patients with psoriasis: preliminary outcome

M Knop, H Wojak, N Maier, S Salzer, F Ruëff

PSORIASIS VULGARIS AND PHOTOKOEBNERIZATION

Mc Koska, As Karadag, Ms Gurel

Improvement in the quality of life of patients with severe plaque psoriasis treated with systemic methotrexate: a prospective, randomized, open-label, parallel group study in 60 patients

C Krishna, N Parmar

Analysis of Dermatological Life Quality Index in psoriasis patients in a tertiary care hospital

Parimalam Kumar

Usefulness of Fibro Scan in assessing liver fibrosis in adult patients with psoriasis

Parimalam Kumar, Suchithra Ganapathi

Topical corticosteroid decreases CD8+CD103+ skin resident memory T cells in psoriasis, but allows a part of cells to remain in the suprabasal epidermis

Kazuo Kurihara, Toshiharu Fujiyama, Taisuke Ito, Yoshiki Tokura

Myelodysplastic Syndrome in Psoriasis

Dr Manjusha Rajendra Kuruwa

Secukinumab showed more than PASI 90 irrespective of biologic experience in Korean patients with moderate to severe plaque-type psoriasis: the one-year experience of a single center

S.h. Kwon, E.s. Lee

Evaluation between association psoriasis and autoimmune disease

K Laamari, S Elloudi, Z Douhi, H Baybay, Fz Mernissi

Dermoscopy of ungueal psoriasis

K Laamari, S Mrabat, S Zinoune, Z Douhi, S Elloudi, H Baybay, Fz Mernissi

Pustular Psoriasis

K Laamari, S Mrabat, S Zinoune, Z Douhi, S Elloudi, H Baybay, Fz Mernissi

Screening of psoriatic arthritis, by the dermatologist: a systematic review of the methodological quality of patient reported questionnaires.

V Landini, M-a Morales-sanchez, Ml Peralta-pedrero, F Jurado-santa Cruz

Efficacy of Adalimumab in Difficult-to-treat Psoriasis

C Lanna, A Zangrilli, M Bavetta, L Bianchi

Long-term Efficacy and Safety of Brodalumab by Geographic Region

M Lebwohl, K Papp, P Mease, A Gottlieb, A Jacobson, R Pillai

Clinical characterization of a cohort of patients with psoriasis in a specialty center in Chile: 2011-2017 experience using biologics

C Lecaros, J Dunstan, C De La Cruz

Estimation of psoriasis incidence and its dependence on latitude in Chile

C Lecaros, J Dunstan, F Villena, C De La Cruz

Facial psoriasis as a therapeutic challenge: a case series

Daniela Ledic Drvar, Romana Ceovic

Weight-Based Analysis of Psoriasis Area and Severity Index Improvement At 52 Weeks of Risankizumab or Ustekinumab Treatment: An Integrated Analysis of Patients With Moderate-to-Severe Plaque Psoriasis

C Leonardi, K Gordon, M Longcore, Y Gu, L Puig

Safety of Risankizumab in Patients With Moderate-to-Severe Psoriasis: Analysis of Pooled Short-Term and Long-Term Clinical Trial Data

C. Leonardi, H. Bachelez, J.j. Wu, R. Sinvhal, J. Valdes, B. Waterhouse, W.c. Valdecantos, M. Lebwohl

Clinical Efficacy of Thalidomide combined with Avermectin A in the treatment of Generalized Pustular Psoriasis

Juan Li, Zhen Xie, Ling Li, Zhu Shen

Effects of tumor necrosis factor-like ligand 1A (TL1A) on imiquimod-induced psoriasiform skin inflammation in mice

Lin Li

Expression of Death Receptor 3 (DR3) on Peripheral Blood Mononuclear Cells (PBMCs) in Patients with psoriasis vulgaris

Lin Li

Bach2 regulates the expression and function of Th17/Treg cells in psoriasis

R Li

Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting NFκB and TLR7 pathway in mice

Yj Li, Gy Zhang, Ml Chen, M Tong, M Zhao, F Tang, R Xiao, Hq Wen

High-throughput RNA sequencing analysis of effects of angelica polysaccharide on HaCaT

Linli Liu, Chunshui Yu

Why we are different: Sex associated methylation differences in psoriasis

Mar Llamas-velasco, Ancor Sanz-garcia, Alejandra Reolid, Ester Muñoz-aceituno, Lola Alonso-guirado, Esteban Dauden, Francisco Abad-santos, Maria Carmen Ovejero-benito

Ixekizumab for severe psoriasis in a liver transplant recipient

Viviana Lora

Pediatric pustular psoriasis and growth failure : is there a relationship?

O Magdoud, H Hammami, T Bacha, A Zaouak, S Fenniche

Management of pustular psoriasis during pregnancy: is the use of cyclosporine a real solution?

O Magdoud, A Zaouak, W Sassi, S Ben Jannet, H Hammami, S Fenniche

Case-control study to identify predictors of significant liver fibrosis in patients with psoriasis as detected by transient elastography

Rahul Mahajan, Sunil Dogra, Sanjeev Handa, Mohammed Razmi T, Tarun Narang, Sahaj Rathi, Radha Krishan Dhiman, Biman Saikia, Adil Karim

The top ten research priorities for psoriasis

R Majeed-ariss, M Mcphee, H Mcateer, H Young

FACTORS PREDICTING PRURITUS IN PSORIASIS

S Mansouri, C Ebongo, N Ismaili, L Benzekri, K Senouci, B Hassam

STUDY OF TH17 PATHWAY IN PSORIATIC PATIENTS USING CYCLOSPORIN

A Mascarenhas, A Pavez, E Lago, S Carneiro

Real life clinical use of Secukinumab in bio-naive and bioswitched patients with psoriasis: a two centres experience

Paola Mascia, Alain Taïeb, Francesco Loconsole, Julien Seneschal, Antonio Carpentieri, Marie Beylot-barry, Caterina Foti, Domenico Bonamonte

Psoriasis Patients Profile in a University Hospital in Munich, Germany

R Mattjie, A Zink, T Biedermann, K Eyerich

Gender and age-related patient needs in psoriasis care

J Maul, A Navarini, R Sommer, F Anzengruber, C Sorbe, U Mrowietz, C Blome, W Boehncke, D Thaci, C Reich, N Yawalkar, C Mainetti, E Laffitte, M Streit, S Rustenbach, C Conrad, L Borradori, M Gillet, A Cozzio, P Itin, P Häusermann, L French, M Augustin

Secukinumab in real life: a 2-year multicenter retrospective study in Campania region

M. Megna, L. Di Costanzo, G. Argenziano, A. Balato, P. Colasanti, F. Cusano, A. G. Galluccio, A. Gambardella, S. Lembo, R. Mozzillo, G. Scotto Di Luzio, N. Balato

Psoriasis frequency and features in common variable immunodeficiency patients

M. Megna, A. Pecoraro, N. Balato, A. Villani, L. Crescenzi, A. Balato, G. Spadaro

Succesful treatment of poor steroid response-flare up of Impetigo Herpetiformis

Jorida Memini, Artan Dafa, Loreta Kuneshka

IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17 treatment

Laura Mercurio, Martina Morelli, Claudia Scarponi, Elan Eisenmesser, Gianluca Pagnanelli, Emanuela Gubinelli, Cinzia Mazzanti, Andrea Cavani, Charles A. Dinarello, Cristina Albanesi, Stefania Madonna

Real-World Efficacy of Apremilast in Patients With Moderate Plaque Psoriasis: Results From the Corrona Psoriasis Registry

J Merola, A Gottlieb, R Mclean, J Cirulli, C Williams, G Linowski, H Litman, N Guo, K Emeanuru, B Strober

Assessment of uric acid levels in chronic plaque psoriasis

Wessam Metwally, Fatma Abdalsalam, Laila Rashed, Rania Madi

Efficacy and safety of ixekizumab in psoriatic patients pretreated with biologics

Gaia Moretta, Giacomo Caldarola, Federico Pirro, Laura Calabrese, Magda D'agostino, Clara De Simone, Ketty Peris

Interleukin- 17 as a marker of metabolic syndrome in psoriasis vulgaris

Hanan Morsy, Sara Awad

Elevated self-disgust in psoriasis patients

S Moschogianis, D Wilkinson, M Aruketty, S Mckie, C.e.m Griffiths, R Elliott, C.e Kleyn

Successful treatment with secukinumab of 3 dialysis patients with psoriasis vulgaris and psoriatic arthritis

Miho Mukai, Yuichi Kurihara, Yoshihiro Ito, Hayato Takahashi, Masayuki Amagai, Noriko Umegaki-arao

The study of changes in the indices of the immune system in psoriasis.

Javlon Mullakhanov

Secukinumab in HIV-positive patient with cutaneous and arthropathic psoriasis

M Nacca, L Boccia

NEW ASPECTS IN PSORIASIS PATHOGENESIS

Liudmyla Naumova, Roman Stepanenko, Victor Stepanenko

Low Vitamin D in Psoriasis: Reality or Myth?

Preethi B. Nayak, Banavasi Shanmukha Girisha, Tonita Mariola Noronha

Use of transient elastography in detection of liver fibrosis in psoriasis patients of Indian origin

Shekhar Neema

New perspectives on psoriasis, interleukins and curcumin

E. Niculet, A.l. Tatu

Topical 5-Flurouracil in the management of nail Psoriasis

S Odedra, T N Shim

Cancer and psoriasis: to treat or not to treat with biological therapy?

Giulia Odorici, Andrea Conti, Claudia Lasagni, Laura Bigi, Giovanni Pellacani

Acute Methotrexate Toxicity: in Cases of Generalized Pustular Psoriasis

Riyana Noor Oktaviyanti, Rahmadewi Rahmadewi, Cita Rosita Sigit Prakoeswa

Acute Anterior Uveitis in a Patient with Psoriasis

Hazel H. Oon, Sp Chee, Hla Sandar, Genevieve Ho

Dyslipidaemia, antioxidants and other risk factors for atherosclerosis – is their unfavorable profile directly related to psoriasis?

Magdalena Oszukowska, Zofia Gerlicz-kowalczuk, Magdalena Kozlowska, Aleksandra Lesiak, Andrzej Kaszuba, Joanna Narbutt

Safety and Efficacy of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: Results From a Phase 2 Open-Label Study

A Paller, E Becker, R De Lucas, M Paris, W Zhang, Z Zhang, C Barcellona, P Maes, L Fiorillo

VITAMIN D SUPPLEMENTATION AND PSORIASIS

M Panduru, Lg Simon, D Orasanu, Nm Panduru

Sleep disturbances in psoriasis patients: a pilot study using wrist actigraphy

K. Pantelidi, K. Vlami, K. Theodoropoulos, I. Kapniari, A. Diakomopoulos, M. Dalamaga, E. Papadavid, S Papiris

Disease Characteristics of Patients Receiving Secukinumab Therapy for Moderate to Severe Chronic Plaque Psoriasis in the PURE Registry: Year 1 vs. Year 2

K.a. Papp, M. Gooderham, L. Albrecht, V. Ho, H. Lima, D Sajic, I. Turchin, E. Rampakakis, A. Vieira, L. Rihakova

Secukinumab Demonstrates Sustained Effectiveness in Treating Patients with Moderate to Severe Plaque Psoriasis: 24 Month Follow-up Data from PURE Registry

Ka Papp, M Gooderham, C Lynde, J Beecker, Ms Alam, R Haydey, R Langley, E Rampakakis, A Boucher, A Vieira, L Rihakova

Disseminated Tuberculosis Found in a Psoriasis Patient After an Adalimumab Treatment

Hai-jin Park, Seung Pil Ham, Jae Hong Oh, Hee Jae Park, Mira Choi

Coexistence of three autoimmune diseases: therapeutic approach in a Filipino adult woman

Mn Pascasio

The levels of neutrophilic serine proteases in the skin of patients with lesional psoriasis

Aleksei Pashkin, Alexander Zhukov, Vladislav Khairutdinov, Aleksei Samtsov, Tazhir Mametnabiev, Alexander Garabagiou

Psoriasis is associated with significant hospitalization for psychiatric illnesses and mental health emergencies: A national inpatient sample

K Patel, H Lee, S Rastogi, V Singam, P Vakharia, J Silverberg

Multidisciplinary management of psoriasis and psoriatic arthritis: 6 years of experience

S Pérez-barrio, Mj Calderón-gutiérrez, M Zaldúa-arrese, I Calvo-zorrilla, B Ramos-bareño, N González-romero, A Lobato-izagirre, R Izu-belloso

An International Delphi survey to define screening for psoriatic arthritis and measurement of psoriatic arthritis symptoms in psoriasis clinical trials

L Perez-chada, A Gottlieb, J Cohen, K Callis Duffin, A Garg, J Latella, A Armstrong, A Ogdie, J Merola

Development of the ‘PsO Sleepy-Q’ and the ‘PsA Sleepy-Q’: two questionnaires to characterize sleep in patients with psoriatic disease

L Perez-chada, E Klerman, J Li, D Perez-chada, A Gottlieb, J Merola

Selecting Core Outcome Measures For Psoriasis Clinical Trials: A Systematic Review Of The Measurement Properties Of Investigator Global And Patient Global Assessment Measures

L Perez-chada, N Salame, A Ford, K Callis Duffin, A Gottlieb, A Garg, J Latella, J Merola, A Armstrong

PATTERN OF DRUG USE IN PATIENTS WITH PSORIATIC ARTHRITIS: STUDY IN A REAL-WORLD SETTING IN ITALY.

Valentina Perrone, Serena Losi, Erica Filippi, Veronica Filippi, Diego Sangiorgi, Stefano Buda, Silvia Antonelli, Luca Degli Esposti

PATTERNS OF USE OF SYSTEMIC THERAPIES IN PSORIASIS PATIENTS IN AREAL-WORLD SETTING IN ITALY.

Valentina Perrone, Serena Losi, Alessia Maiorino, Diego Sangiorgi, Stefano Buda, Silvia Antonelli, Luca Degli Esposti

Prevalance of Hypocalcaemia and Streptococcal Infection in Psoriasis Vulgaris

Rahul Pillai, Ambujam S, Srikant Shanmugham

MULTIPLE PARADOXICAL REACTIONS DURING IXEKIZUMAB THERAPY

F Pirro, G Moretta, G Giovanardi, B Fossati, G Caldarola, K Peris, C De Simone

THE EFFECT OF THE AVÈNE THERMAL CURE ON THE PSORIASIS ASSOCIATED PRURITUS

D Placintescu, S Petit, D Guerrero, C Jean Decoster

Successful Treatment of Recalcitrant Pediatric Generalized Pustular Psoriasis Patients with anti-TNF-α therapy: A Case Series from a Tertiary Center in Turkey

A Polat Ekinci, G Babuna Kobaner, Gp Sun, Z Yilmaz

Successful treatment of palmoplantar pustulosis with brodalumab. Two cases report

Maria Politou, Anastasios Giannoukos, Maria Pompou, Nikolaos Fekkas

Adalimumab Efficacy in Nail Psoriasis by Baseline Subgroups, and Overall Safety from First 26 Weeks of a Phase-3, Randomized, Placebo-Controlled Trial

Y Poulin, A Kavanaugh, J Lambert, E Soriano, T Albuquerque, Z Geng, Y Gu, O Reyes Servin, J Crowley

Meta-analysis of Four Phase 3 Trials by Machine Learning Revealed Predictors that Indicate Additional Benefit of Secukinumab 300 mg Over 150 mg in Psoriatic Arthritis

Luminita Pricop, Corine Gaillez, Gregory Ligozio, Xuan Zhu, Davida James

How is pollution involved in the development and/or exacerbation of psoriasis and atopic dermatitis?

Roxane Prieux, Giuseppe Valacchi, Franco Cervellati

Interleukin-22 and skin: from epidermal homoestasis to psoriasis

Francesca Prignano, Elena Donetti

Improvement in Absolute Psoriasis Area and Severity Index (PASI) Score Through 3 Years of Continuous Treatment with Guselkumab in the VOYAGE 1 Trial

L Puig, Kb Gordon, T-f Tsai, D Thaci, M Gooderham, S Fakharzadeh, S Li, Y-k Shen, K Reich

Association of waist circumference with severity of Psoriasis - A cross sectional study

Palvisha Qadri, Saadia Tabassum

Microbiome community analysis identifies imbalance between Propionibacterium and Corynebacterium as characteristics of psoriatic lesion

Cheng Quan, Jie Zheng

INTERLEUKIN 31 IS HYPEREXPRESSED IN THE SKIN LESIONS OF PATIENTS WITH PSORIASIS.

L Quintarelli, R Maglie, D Bonciani, W Volpi, B Bianchi, E Del Bianco, M Caproni

Childhood psoriasis : a descriptive study

Faten Rabhi, Malek Ben Slimen, Ines Chabchoub, Wissal Abdelli, Soumaya Youssef, Kahena Jaber, Mohamed Raouf Dhaoui

Overweight in childhood psoriasis: A case-control study

Faten Rabhi, Malek Ben Slimen, Soumaya Youssef, Kahena Jaber, Mohamed Raouf Dhaoui

Melanoma and squamous cell carcinoma in patient with severe pustular psoriasis

Faten Rabhi, Soumaya Youssef, Malek Ben Slimen, Ines Chabchoub, Kahena Jaber, Mohamed Raouf Dhaoui

Efficacy of continuous ixekizumab treatment over 60 weeks in systemic-naïve patients and after switching from methotrexate

M A Radtke, K Fotiou, L Berggren, A Leutz, K Reich

Cost effectiveness in the treatment of psoriasis with PUVA -therapy in Uzbekistan

Zarina Rakhmatova, Ilona Nazarova

Psoriasis: A Decade of Experience in a State Hospital in Peninsular Malaysia

Rajalingam Ramalingam, Nurnadwa Z Sabri, Nurulain Hussin, Noorzana M Zakaria

Die: hydrate folate reducatse

Dr.heera Ramesh, Dr.leelavathi B

Magnetic resonance elastography and hepatogram as a non-invasive tool for detecting and quantifying hepatotoxicity in psoriasis patients receiving methotrexate.

N Ranka, A Parthasaradhi, V Bhaskar

Facial involvement in Indian psoriatic patients and its association with disease severity and metabolic syndrome- a cross-sectional study

P.s.s Ranugha, Priya Bishnoi, Laxmisha Chandrashekar

Significance of PASE score in psoriasis: A cross-sectional study in a tertiary care hospital.

Deepthi Ravi, Jayakar Thomas

Ixekizumab Treatment Results in More Rapid and Sustained Resolution of Patients’ Itch, Skin Pain and Improvement in Quality of Life in Patients With Moderate-to-Severe Psoriasis Compared to Ustekinuma

K Reich, R Burge, D Shrom, D Amato, B Zhu, G Gallo, Y Dong, B. Elewski

Physician- and Patient-Reported Outcomes for Patients With Plaque Psoriasis Treated With Apremilast During Routine Dermatology Care in Germany

K Reich, S Fritzlar, B Korge, M Manasterski, U Schwichtenberg, S Morys`, M Lampl, J Roemmler-zehrer, N Núnez Gómez

Sustained Improvement in General Health-Related Quality Life and Work Productivity in Patients with Moderate to Severe Psoriasis Treated with Guselkumab: 3-Year Data from Clinical Trial VOYAGE 2

K Reich, Kb Gordon, P Foley, M Lomaga, C Han, M Song, Y-k Shen, Ma Radtke, Jj Wu, A Armstrong

Long-term safety of tildrakizumab in patients with moderate-to-severe plaque psoriasis: incidence of malignancies through 3 years (148 weeks) from reSURFACE 1 and reSURFACE 2 phase 3 trials

K Reich, Cem Griffiths, J Lambert, L Iversen, A Peserico, Ab Kimball, I Pau-charles, A Blauvelt, D Thaçi

Clinical response of fumaric acid esters in psoriasis: Registry data from 1,409 patients in Germany

K Reich, U Mrowietz, D Thaci, C Sorbe, Ma Radtke, Sj Rustenbach, L Kühl, M Augustin

Maintenance of Response Through Up to 3-Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Trial

K Reich, M Song, B Randazzo, S Li, Y-k Shen, C Han, A Armstrong, P Foley, Kb Gordon

Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in psoriasis patients over 5 years

K. Reich, A. Blauvelt, A. Armstrong, R. Langley, A. De Vera, F. Kolbinger, S. Spindeldreher, M. Ren, G. Bruin

Immunogenicity of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis during a 52-week treatment period

K. Reich, A. Blauvelt, A. Armstrong, R. Langley, A. Deodhar, D. Gladman, I. Mcinnes, L. Pricop, B. Porter, J. Safi, A. Shete, M. Ren, A. De Vera, S. Spindeldreher, F. Kolbinger, G. Bruin

Malignancy Rates in Patients With Moderate-to-Severe Psoriasis Treated With Risankizumab: Analysis of Pooled Short-Term and Long-Term Clinical Trial Data

K. Reich, K.b. Gordon, S. Tyring, R. Sinvhal, A. Camez, B. Waterhouse, W.c. Valdecantos, K. Papp

Fatal failure of tuberculosis test in psoriasis treatment with a TNF alpha blocker

R Reinert, M Radtke, M Augustin

Elderly psoriatic patients under biological therapies: an Italian experience

Federica Ricceri, Federico Bardazzi, Andrea Chiricozzi, Paolo Dapavo, Francesca Ferrara, Cristina Mugheddu, Marco Romanelli, Franco Rongioletti, Francesca Prignano

Improvement in Psoriasis Scalp Severity Index (PSSI) during Maintenance Treatment with Mirikizumab

P Rich, P Klekotka, D Patel, J Tuttle, J Li, K Papp, R Bissonnette

Management approach of Psoriatic Arthritis based on clinical and radiographic manifestations of the disease as indicators of the predominant immunopathological pathway. One step closer to treatment o

Joaquin Rivas-bejarano, William Abramovits

Apremilast Prior To Biologics In Psoriasis

J Robinson, L Price, G Melendez

The Prevalence of Genital Psoriasis in Patients Initiated on Biologic Therapy

J Robinson, L Price, G Melendez

Efficacy and Survival of Biologic Agents in psoriasis.

H Roche, K Bouiller, E Puzenat, E Deveza, B Roche-kubler, F Pelletier, A Van De Laak, As Dupond, C Nardin, F Aubin

Development Of Psoriasis While Receiving Allergen Immunotherapy: A New Rash, An Old Debate, A Redherring

M Rodenas, C Lamb, A Debenedetto

A generalized Blaschko linear congenital eruption

Amadeu José Rodrigues Queiróz, Mariana Carvalho Costa, Fabiana Covolo De Souza Santana, Elaine Valim Camarinha Marcos, Gustavo Henrique Takano, Gladys Aires Martins

Impact of Body Mass Index and Obesity on Clinical Response to Secukinumab Treatment for Psoriasis in 5 Dermatology Units un Andalucia ( Spain).

L Rodriguez Fernandez-freire, R Ruiz Villaverde, M Galan, L Martinez Pilar, Jc Armario Hita

IL-17C is responsible for keratinocyte hyperproliferation and sustained inflammation associated with psoriasis

F Rodriguez-bolanos, M Gooderham, K Papp

DRUG SURVIVAL OF USTEKINUMAB IN 8 YEARS OF USE AT THE DERMATOLOGY UNIT OF UNIVERSITY OF CAMPANIA “LUIGI VANVITELLI”

F Romano, A Lo Schiavo

EFFICACY OF IXEKIZUMAB IN DIFFICULT-TO-TREAT AREAS: FACE AND GENITAL PSORIASIS.

F Romano, A Lo Schiavo

THE LONGTERM SAFETY AND RATE FREQUENCY OF NEW ONSET INFLAMMATORY BOWEL DISEASE IN PATIENT WITH PSORIASIS TREATED WITH IL17 INHIBITORS: OUR EXPERIENCE

F Romano, A Lo Schiavo

Psoriasis and Fahr’s syndrome

S Saad, Y Soua, S Boumaisa, M Korbi, H Belhadjali, M Youssef, J Zili

Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study

Pooja Sagar, Thaci D

Epidemiological profile of psoriasis patients treated at the dermatology department of the university hospital of Sergipe.

F Santos, P Oliveira

The correlation between dermatology life quality index and psoriasis area severity index in psoriatic patients treated with adalimumab

Mi Sarbu, M Tampa, C Mitran, M Mitran, C Matei, C Hristia, A Sarbu, Sr Georgescu

CASE REPORT: PUSTULAR PSORIASIS CONFUSING WITH ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS (AGEP)

Desiana Widityaning Sari, Evy Ervianti

Depression, anxiety disorder and psoriasis

Silke Schagen, Andrea Bartenschlager, Chiara Cicero, Keidler Doris, Julia Melcher, Dr. Schwinn Andreas

In-vitro evaluation of antipsoriatic activity of sulphated algal polysaccharides extract with 3D psoriatic autologous skin substitute

Rachelle Seguin, Antoine Labat, Estelle Loing, Roxane Pouliot

Safety and efficacy profile of oral cyclosporine versus oral methotrexate versus oral acitretin in palmoplantar psoriasis – A prospective investigator blind randomized controlled comparative trial.

Samkit Shah, Balkrishna Nikam

Comparison of Safety Outcomes for Treatments of Moderate to Severe Plaque Psoriasis through a Network Meta-Analysis

N Shear, A Joshi, J Zhao, K Betts, R Sinvhal, P Gisondi, S Kalabina, D Williams, A Armstrong

Psoriasis, metabolic syndrome and adipokines; a study on establishing pathophysiological link.

Manjunath Shenoy, Chetana Shenoy

Infliximab in Treatment of Moderate-to-Severe Plaque Psoriasis in Chinese Patients

Yuling Shi, Smriti Subedi, Yu Gong, Youdong Chen, Qian Yu, Yao Wang, Hui Xu, Tengfei Qi, Mei Shi, Juan Wu, Huaijian Zhang

Severe psoriasis is associated with gastrointestinal symptoms, intestinal barrier dysfunction and increased plasma concentration of gut microbiota-derived metabolites.

M Sikora, M Chrabaszcz, M Olszewska, L Rudnicka

Management of Psoriasis using basic tools in resource poor setup : a study of 33 patients with co morbid conditions followed up for 5 years and 3 months.

Vinay Singh

BIOLOGIC THERAPY OF PSORIASIS IN HAEMODIALYZED PATIENTS. A REPORT OF THREE CASES

Urbancek Slavomir, Pecova Tatiana, Vorcakova Karolina, Martinaskova Klara, Bielikova Marianna

Glycyrrhizinic acid as a new drug in the complex therapy of psoriasis

Vladimir Sobolev, Anna Soboleva, Eugeniya Dvoryankova, Anastas Piruzyan, Elena Denisova, Malika Denieva, Irina Korsunskaya

Developing a therapeutic window for secukinumab in psoriasis: a step towards personalized therapy

R Soenen, E Meulewaeter, L Grine, L Temmerman, S Lanssens, E Brouwers, N Van Den Berghe, J Lambert, A Gils

Perception of stigmatization of people with psoriasis – a qualitative analyses from patients perspective, their relatives and health care providers

Rachel Sommer, Matthias Augustin, Ulrich Mrowietz, Janine Topp, Ines Schäfer, R Von Spreckelsen

Perception and predictors of prejudice in people with psoriasis in the German population

Rachel Sommer, Janine Topp, Ulrich Mrowietz, Ines Schäfer, Marc Alexander Radtke, Ralph Von Kiedrowski, Matthias Augustin

A multi-source real-world overview of prior and concomitant therapies among patients treated with secukinumab

C Sorbe, L Kühl, L Mayerhoff, M Augustin, Ma Radtke, K Reich

Pharmakovigilance of systemic antipsoriatic treatment: Results from more than 11,000 patient years in the German Psoriasis Registry PsoBest

C Sorbe, L Kühl, Sj Rustenbach, R Von Kiedrowski, Ma Radtke, M Augustin

Systemic therapy of psoriasis in pregnancy, lactation and fertility phase: Practical aspects

B Stephan, Ma Radtke, M Augustin

Risankizumab is Associated With Low and Consistent Infection Rates in Patients With Moderate-to-Severe Psoriasis: Analysis of Short-Term and Long-Term Pooled Clinical Trial Data

B. Strober, A. Blauvelt, A. Menter, R. Sinvhal, J. Valdes, B. Waterhouse, H. Photowala, D. Thaçi

PSORIASIS AND UVEITIS

L Suar, C Busso, S Golbert, P Figueroa, A Parigini, C Barbini, L Eimer

Identification of Leishmania DNA in psoriasis and/or psoriatic arthritis patiens under immunosupressive treatment

Fernanda Suelen Jacques Sousa De Assis, Patricia Shu Kurizky, Lais Mitsue Tanaka Gonçalves, Fernanda Ferraço Marianelli

Enhanced Cyr61 levels in patients with psoriasis vulgaris (PV)

Qiao-mei Sun, Chen Tao, Li-xin Fu

Decreased interleukin-35 serum levels and altered interleukin-35 expression in patients with psoriasis vulgaris

Qiaomei Sun, Tao Chen, Lixin Fu, Jin Wang, Hao Yang

Effects of phototherapy on serum Interleukin 1(IL-1), IL-4, IL-8, IL-17, IL-37, Interferon-gamma (IFN- γ), Chemokine ligand 1 (CXCL1) levels in psoriasis vulgaris patients

Hulya Suslu, Ayse Serap Karadag, Hayriye Erman, Eray Kirac, Mehmet Salih Gurel, Necmettin Akdeniz

Global Psoriasis Atlas - Identifying unpublished data and developing methodologies for field survey of psoriasis

N Suthakharan, S Gupta, J Augustin, C Griffiths, J-t Maul, M Augustin

Skin Tissue Expression and Serum Level of Thymic Stromal Lymphopoietin: An Analysis Study in Psoriasis Patients

Oki Suwarsa

Psoriatic arthritis induced by intravesical Bacillus Calmette-Guerin infusion for bladder cancer : successfull treatment with apremilast

Eleftheria Tampouratzi, John Katsantonis

Successful treatment with apremilast psoriatic patient with underlying chronic hepatitis B

Eleftheria Tampouratzi, Spyridon Vrakas, Georgios Koutoufaris, Vasileios Xourgias, John Katsantonis

Unintended pregnancy during treatment with methotrexate and etanercept for psoriasis – Case Report

Lm Tanaka Gonçalves, F Suelen Jacques Sousa De Assis, F Ferraço Marianelli, K Fernandes De Oliveira, C Bresolin Pompeu, N Souza Medeiros, L Borges De Souza, P Shu Kurizky, G Aires Martins

Long term efficacy of adalimumab in patients with psoriatic arthritis monitored by clinical and US-PD evaluation: a 7-year retrospective study

M Teoli, A Zangrilli, M Bavetta, R Perricone, M S Chimenti, L Bianchi

Nine-Year Interim Real-World Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis from the ESPRIT Registry

D Thaçi, Y Poulin, W Valdecantos, M Bereswill, D Arikan, D Guo, H Kupper, K Papp

The German National Registry on Psoriasis: Current status, profiles, impact for health care

D Thaci, K Reich, Wh Boehnke, A Enk, U Mrowietz, P Staubach-renz, K Strömer, R Von Kiedrowski, C Sorbe, M Augustin

Long-term safety of tildrakizumab in patients with moderate-to-severe plaque psoriasis: incidence of severe infections through 3 years (148 weeks) from reSURFACE 1 and reSURFACE 2 phase 3 trials

D Thaçi, K Reich, J Lambert, L Iversen, A Peserico, Ab Kimball, I Pau-charles, A Blauvelt, Cem Griffiths

Obesity and Psoriasis: a case series.

R Tiberio, F Graziola, B Miglino, P Savoia

Predictive variables of clinical course in psoriatic patients in systemic treatment

Rossana Tiberio, Francesca Graziola, Benedetta Miglino, Laura R.g. Rigoni, Paola Savoia

Is there any difference between antiTNF-α induced paradoxical psoriasiform reactions and psoriasis?

Ll Tirelli, Pc Luna, Ld Mazzuoccolo, B Ferrari, Mt González Baschiera, Jj Solé, Aa Panizzardi, A Schvartz, A Daconte, Ml Cassará, Cm Luna, M Larralde

Access to information on psoriasis treatment and disease: Which different sources do patients use? Results from an international survey

Tiago Torres, Anwar Al Hammadi, Ayman M Elgendi, Martin Dossenbach, Daniel Saure, Cláudia Sá E Cunha, Mohamed Elrayes

Zinc and psoriasis

A Traniello Gradassi, A Patrizi

Psoriasis Vulgaris in Hiv patients

Ela Treko, Migena Vargu, Ermira Vasili

Efficacy and security profile of etanercept biosimilar in Psoriasis

L Tripo, L Pescitelli, E Rosi, A Di Cesare, F Prignano

Tuberculosis – related type of psoriasis – one hypothese which needs more proves

N Tsankov, I Grozdev, J Kazandjieva

SERUM 25-HYDROXYVITAMIN D LEVELS IN PATIENTS WITH PSORIASIS VULGARIS

Zh. Tsokeva, M. Ganeva, T. Gancheva, V. Tsoneva, E. Hristakieva

Mild electrical stimulation with heat shock attenuates the skin inflammation in mouse model of psoriasis

Yu Tsurekawa, Misaki Morita, Masataka Moriuchi, Yoshio Nakano, Mariam Piruzyan, Sanako Fukami, Mary Ann Suico, Tsuyoshi Shuto, Hirofumi Kai

IFN-g, TNF-a and IL-17 pro-inflammatory cytokines regulate the expression of genes involved in miRNA biogenesis in normal and psoriatic keratinocytes

C Tuccilli, S Madonna, E Baldini, C Scarponi, F Persechino, D Giordano, S Persechino, C Albanesi, S Ulisse

High Incidence of Latent Tuberculosis Infection in Indigent Patients Receiving Biologics in New York City.

Nneamaka Ukatu, Maria Hannaway, Jacquelyn Sink, Katherine Rupley, Alice Gottlieb

Understanding the Burden of Moderate Psoriasis in Europe from the Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey

P Van De Kerkhof, J Barker, G Girolomoni, R Langley, L Puig, K Reich, J Cirulli, M Lebwohl

Utility of monitoring ustekinumab levels in psoriasis patients: clinical response is correlated with intermediate ustekinumab concentrations

N Van Den Berghe, E De Keyser, R Soenen, L Meuleman, S Lanssens, A Gils, J Lambert

METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS. A CASE CONTROL TYPE STUDY IN QUITO – ECUADOR

Cristian Vasquez, Luz Maria Dressendorfer

Koebnerization leading to zosteriform Psoriasis

Parul Verma

Mild to Moderate Scalp Psoriasis: A Successful Algae-Based Treatment

C Vincenzi, B Marisaldi, A Tosti

Certolizumab Pegol on plaque psoriasis: efficacy and safety at one year of treatment.

Laura Vollono, Valeria Manfreda, Mauro Mazzeo, Annunziata Dattola, Luca Bianchi

Mechanical stretch exacerbates psoriasis by stimulating keratinocyte proliferation and cytokine production

G Wang

Oncostatin M Upregulated Livin Expression Protects Keratinocyte Cells against ROS-Induced Cell Death in Psoriasis Vulgaris

Hao Wang, Fan Rong, Hu Jinsong

Proinflammatory effects of KYNU in psoriasis and its mechanism

Min Wang, Yan Zheng

Risk of thyroid diseases in psoriatic patients: a nationwide cohort study

Shu-hui Wang, Ching-chi Chi, Jui Wang, Yu-sheng Lin, Tao-hsin Tung

CD8+CD69+ TRM cells hold immunological memory by IL-15 in psoriatic recurrence

Siyu Wang, Ling Chen, Chaonan Sun, Zhu Shen

Proteomic analysis and quantification of lysine crotonylation in psoriatic lesions

Wj Wang, Q Zhen, B Li, J Wu, Hy Ge, Ld Sun

Oncostatin M regulated senescence-autophagy interaction in keratinocyte in the pathogenesis of psoriasis

Yujia Wang, Xian Jiang, Gu He

Hospital Anxiety and Depression Scale reductions demonstrated with secukinumab in psoriasis patients who have failed anti-TNFalpha biologics; Results from the SIGNATURE study

R Warren, J Barker, A Burden, A Finlay, Y Armendariz, R Williams, C Griffiths

The Simplified Psoriasis Index is responsive to changes resulting from treatment with secukinumab: findings from the SIGNATURE study of patients who had previously failed anti-TNFalpha agents

R Warren, A Finlay, C Griffiths, J Barker, A Burden, R Williams, Y Armendariz, R Chalmers

THE EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN A RECALCITRANT ADOLESCENCE PSORIASIS PATIENT WITH FATTY LIVER: A CASE REPORT

Ni Putu Susari Widianingsih, Cita Rosita Sigit Prakoeswa

GLOBAL, REGIONAL, AND NATIONAL BURDEN OF PSORIATIC DISEASE ESTIMATES FROM THE GLOBAL BURDEN OF DISEASE 2016 STUDY

Dongze Wu, Cui Guo, Priscilla Wong, Lai-shan Tam

Long-Term Efficacy of Ixekizumab and Absolute Psoriasis Area and Severity Index Response in Patients with Moderate-to-Severe Psoriasis: 4 Years of Follow-up from UNCOVER-3

J Wu, J Bagel, R Langley, G Gallo, L Zhang

Change in body weight and body mass index in psoriasis patients receiving biologics: a meta-analysis

My Wu, Sj Yang, Cc Chi

The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis

Yumin Xia, Jingang An, Dingwei Zhang

Fn14 deficiency ameliorates psoriasis-like skin disease in a murine model

Yumin Xia, Lingling Peng, Qingyan Li

PPAR-β/δ plays an important role in the pathogenesis of psoriasis and dyslipidemia comorbidity

Xinran Xie, Lei Zhang, Xue Li, Ping Li

A Critical Role of the IL-1β-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis

Feng Xue

Psoriasis and tinea: Interleukin-17 mediated manifestation

Shinya Yamamoto, Shinichi Imafuku, Keiichi Yamanaka

The concept of Inflammatory skin march: IL-1–mediated skin inflammation and cerebrovascular and cardiovascular events

Keiichi Yamanaka, Yoshiaki Matsushima, Kento Mizutani, Karin Okada, Ai Umaoka, Eri Rikiishi, Makoto Kondo, Koji Habe

Effectiveness and Safety of Methotrexate for Chinese Psoriatic Patients with and without Arthritis: A Prospective Cohort Study

Kexiang Yan, Yuanjing Zhang, Jinhua Xu, Xuejun Zhang

Enhanced serum interferon-lambda 1 interleukin (IL)-29 levels in patients with psoriasis vulgaris (PV)

Hao Yang, Tao Chen, Li-xin Fu, Qiao-mei Sun, Pei-mei Zhou, Li-wen Zhang

Clinical Experience of Secukinumab Use in Psoriasis: A Malaysian Perspective

Felix Boon-bin Yap

Association and Prediction of Serious Infection in Patients with Psoriasis on Biologic Therapies: A Cohort Study from the British Association of Dermatologists Biologics and Immunomodulators Register

Zenas Yiu, Mark Lunt, Darren Ashcroft, Christopher Griffiths, Richard Warren, Badbir Study Group Badbir Study Group

THE INVESTIGATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENE POLYMORPHISM AS A PHARMACOGENETIC MARKER TO EVALUATE BIOLOGICAL TREATMENT RESPONSE IN PSORIASIS

Ozge Yontem, Ilteris Oguz Topal, Nagihan Sahillioglu, Ozgur Emek Kocatürk Göncü

A “whole-patient view” and quantification of secukinumab treatment benefits on psoriasis and psoriatic arthritis patients

R You, S Mpofu, J Frueh, L Pricop, K Abrams, Da James, G Ligozio, M Vandemeulebroecke

The molecular mechanism of paeoniflorin regulating keratin 17 expression in the targeted therapy of psoriasis

Chen Yu, Xiaocui Bai, Erle Dang, Gang Wang

Improvement of Glycated Hemoglobin (HbA1c) and Necrobiosis lipoidica in patients with Psoriasis and Diabetes Mellitus treated with apremilast.

E Zafiriou, N Ntavari, E Savvopoulou, A Roussaki-schulze

Effectiveness and cost-effectiveness of biologic treatments for plaque psoriasis in Italy: methodology of the CANOVA observational study.

E Zagni, F Ferri, G Musso, D Colombo

Prevalence of phototherapy in the age of biologics

Arianna Zanca, Piergiacomo Calzavara Pinton, Mariachiara Arisi, Maria Teresa Rossi, Cristina Zane, Marina Venturini, Bernhard Ortel

Barrier analysis of guideline-compliant healthcare for psoriasis in Europe - Interim Report on Polish and German data of the International Study "PsoBarrier EU“

N Zander, M Czarnecka-operacz, A Reich, J Dukart, M Radtke, M Augustin, J Szepietowski, A Langenbruch

Adalimumab for treatment of severe psoriasis in childhood

Arianna Zangrilli, Mauro Bavetta, Laura Diluvio, Annunziata Dattola, Caterina Lanna, Luca Bianchi

Long-Term safety and effectiveness of Adalimumab for psoriasis and psoriatic arthritis: results from 13-years of experience

Arianna Zangrilli, Mauro Bavetta, Caterina Lanna, Luca Bianchi

Generalized pustular psoriasis induced by terbinafine

A Zaouak, H Hammami, S Fenniche

Nail changes as the initial sign of psoriasis

J Zhang, M Zheng, Xy Man

Study on the interferential and regulative role of Chemokine-like Factor 1-C-terminal peptides in psoriasis

Y Zheng, X Zhang, Jy Li, T Liu

RIPK3 bidirectional regulation of keratinocyte fate and its mechanism of action in psoriasis

Yan Zheng

C19, a C-terminal peptide of CKLF1, decreases inflammation and proliferation of dermal capillaries in psoriasis

Yi Zheng, Yanling He, Chengxin Li

Generalized Pustular Psoriasis: A Systematic Review of Systemic Treatments

L Zhou, J Georgakopoulos, A Ighani, J Yeung

IMPORTANCE OF CD123-MARKER IN THE PATHOGENESIS AND THE COURSE OF PSORIASIS

A Zhukov, V Shevchenko, V Khairutdinov, A Samtsov, A Garabadzhiu

Can we achieve long-term optimization of outcomes with flexible adalimumab dosing or discontinuation in stable patients with moderate to severe plaque psoriasis?

S Ziaj, R Abbott, M Kalavala

Brodalumab is effective in hard-to-treat psoriasis that has relapsed after IL-17 targeting biologics: A Real World Study of the Psoriasis in South Wales cohort.

S Ziaj, M Kalavala, V Li, J Hughes, S Kamath, N Ponnambath, G K Patel

Biologics combined with conventional systemic agents for the treatment of psoriasis: 8- year retrospective review from single center in the UK.

Stela Ziaj, Manju Kalavala

HLA-C STATUS IN MODERATE TO SEVERE PSORIASIS PATIENTS TREATED WITH BIOLOGIC TREATMENTS

Ozge Zorlu, Emel Bulbul Baskan, Serkan Yazici, Ilker Ercan, Hayriye Saricaoglu, Kenan Aydogan